Form Type: 4

SEC EDGAR Link
Accession Number:0001144204-14-064137
Date:2014-10-17
Issuer: CORMEDIX INC. (CRMD)
Original Submission Date:

Reporting Person:

TELLEZ CORA M
C/O CORMEDIX INC.
745 ROUTE 202-206, SUITE 303 BRIDGEWATER, NJ US 08807

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.001 PAR VALUE PER SHARE 2014-10-17 P 2,100 a $1.55 2,300 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.05 deemed execution date 0 ( ) 2024-04-03 common stock, $0.001 par value per share 30,000 $2.05 30,000 direct
SERIES C-3 NON-VOTING CONVERTIBLE PREFERRED SOTCK 1.0 deemed execution date 0 ( ) common stock, $0.001 par value per share 50,000 $1.00 5,000 direct
COMMON STOCK WARRANTS (RIGHT TO BUY) 0.9 deemed execution date 0 ( ) 2014-01-08 2020-01-08 common stock, $0.001 par value per share 25,000 $0.90 25,000 direct
Footnotes
IDfootnote
f1 the price reported in column 4 is the weighted average price. these shares were purchased in multiple transactions at prices ranging from $1.548 to $1.55.
f2 these shares vest 1/3 on date of grant, 1/3 on first anniversary of date of grant and 1/3 on second anniversary of date of grant.
f3 on january 8, 2014, the reporting person acquired through a private placement, (i) 5,000 shares of the company's series c-3 non-voting convertible preferred stock, each share convertible into 10 shares of common stock, $0.001 par value per share; and (ii) a five-year warrant to purchase common stock at an exercise price of $1.25 per share. the series c-3 non-voting convertible preferred stock and warrants were purchased together at a purchase price of $10.00 per share. the warrant exercise price was decreased to $0.90 per share effective september 15, 2014.
WhaleWisdom Logo

Elevate your investments